The global Biopsy Devices Market is poised for steady expansion as healthcare systems worldwide intensify efforts toward early disease detection and precision diagnostics. “According to a newly published study by SNS Insider, the global Biopsy Devices Market size valued at USD 2.73 billion in 2025, is anticipated to grow to USD 5.08 billion by 2035, registering a CAGR of 6.52% over the 2026–2035 forecast period.”

The rising cases of cancers and chronic diseases have led to a need for precision in diagnostics procedures to ensure prompt clinical decision-making. Biopsy technology has become a very critical tool for diagnosis in today's healthcare environment where the focus is increasingly on early detection and tailored treatments.

In many hospitals, clinics, and diagnostic centers, healthcare professionals are embracing cutting-edge biopsy technologies that ensure high levels of accuracy in tissue extraction while ensuring minimal discomfort to patients. The rise in the demand for non-invasive approaches has been met by innovation from companies producing biopsies equipment.

Technological Advancements Transform Diagnostic Procedures

Innovation continues to be an important factor that influences the environment for biopsy devices. There is a growing trend among manufacturers of incorporating imaging technology, artificial intelligence, and navigation tools within the biopsy procedure.

There has also been an increasing demand for image-guided procedures in the medical sector, which help doctors locate any suspected tumors with greater precision, thus avoiding any complications associated with the procedure. This trend has been instrumental in increasing the use of advanced biopsy equipment globally.

In light of precision medicine’s increasing popularity, there will be a greater need for quality tissue samples for disease diagnosis and therapy choice in the years ahead, opening new doors for medical device companies.

Key Market Insights Highlight Emerging Opportunities

As far as product category is concerned, needle-based biopsy device captured 43.25% of total market revenue generated in 2025, owing to the extensive use of biopsy devices in various diagnostic procedures in different healthcare facilities.

Furthermore, biopsy guidance system is expected to show the fastest growth rate among all sub-segments over 2026-2035 with an estimated CAGR of 7.63%, owing to the rising demand for image-guided biopsy procedures.

In terms of technology, ultrasound guided biopsy held the largest share in the global biopsy devices market at a revenue share of 32.71%. On the other hand, MRI guided biopsy was anticipated to grow at the fastest rate and record a revenue CAGR of 8.91%, owing to the growing need for visualization during diagnostic procedures.

Further looking into the application segments, breast biopsy procedures captured 36.45% revenue share in the year 2025, attributed to the global breast cancer diagnostic programs and initiatives. However, the most promising application will be that of prostate biopsy procedure which will grow at a rapid rate of 20.76% over 2026-2035.

Expanding Cancer Screening Programs Support Market Growth

Government-led awareness programs and screenings have been playing a major role in promoting the growth of diagnostics in the global market. The growing trend towards diagnosing diseases at an early stage has been leading to an increase in procedure volume.

It is also important to state that specialized diagnosis services are becoming more widely available in healthcare institutions due to growing demand for prompt and precise diagnosis among patients. Such a tendency should ensure sustained growth in the biopsy devices market segment in the long term.

Regional Markets Continue to Create Growth Potential

North America continues to be an important player in global revenue contributions to the market through a highly developed health care sector, increasing acceptance of minimally invasive treatments, and consistent efforts for improving diagnostics technologies. North America enjoys well-recognized reimbursement structures and availability of skilled medical professionals.

Meanwhile, the Asia Pacific region appears to be one of the most promising regions for the growth of the biopsy devices market. This growth is driven by factors, such as healthcare advancements in the region, improvement in diagnostic capabilities, growing awareness about cancer, and healthcare investments.

With continued emphasis by governments on early diagnosis and access to healthcare, the demand for more sophisticated biopsy equipment is anticipated to gain momentum throughout the forecast period in the region.

Leading Companies Focus on Innovation and Expansion

There is stiff competition in the biopsy device industry, since all firms in the industry are committed to investing more in research and development. The industry players are working on making their products highly accurate and ensuring that their operations are efficient.

Key companies operating in the global biopsy devices market include Hologic, Becton, Dickinson and Company, Cook Group, Boston Scientific, Medtronic, Olympus Corporation, Cardinal Health, B. Braun, Siemens Healthineers, and Danaher Corporation.

An SNS Insider analyst commented, “The biopsy devices market continues to benefit from advancements in imaging technologies, increasing emphasis on early diagnosis, and growing demand for precision medicine. As healthcare providers seek more accurate and less invasive diagnostic solutions, innovation will remain a key driver of industry growth.”